Glooko receives FDA clearance for mobile insulin titration tool

Digital diabetes care company Glooko announced today that its Mobile Insulin Dosing System (MIDS) — an app-driven tool that recommends insulin dose adjustments using data collected directly from a patient’s blood glucose meter — has been cleared by the FDA.
Source: mobihealthnews - Category: Information Technology Source Type: news